ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals Inc (MIRM)

44.50
-1.76
(-3.80%)
At close: November 15 4:00PM
44.50
-0.01
( -0.02% )
After Hours: 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
44.50
Bid
43.19
Ask
52.79
Volume
603,822
43.75 Day's Range 46.65
23.14 52 Week Range 48.89
Market Cap
Previous Close
46.26
Open
46.41
Last Trade
1073
@
44.5
Last Trade Time
16:10:26
Financial Volume
$ 26,944,243
VWAP
44.6228
Average Volume (3m)
370,418
Shares Outstanding
47,707,204
Dividend Yield
-
PE Ratio
-12.99
Earnings Per Share (EPS)
-3.43
Revenue
186.37M
Net Profit
-163.42M

About Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC... Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Dover, Delaware, USA
Founded
-
Mirum Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MIRM. The last closing price for Mirum Pharmaceuticals was $46.26. Over the last year, Mirum Pharmaceuticals shares have traded in a share price range of $ 23.14 to $ 48.89.

Mirum Pharmaceuticals currently has 47,707,204 shares outstanding. The market capitalization of Mirum Pharmaceuticals is $2.21 billion. Mirum Pharmaceuticals has a price to earnings ratio (PE ratio) of -12.99.

MIRM Latest News

Mirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD’s The Liver Meeting

- Late-breaker presentation to feature data from VANTAGE study evaluating volixibat in primary biliary cholangitis Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will present...

Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

Third quarter global net product sales of $90.3 million; 2024 guidance increased to $330 - 335 million Volixibat granted breakthrough therapy designation for treatment of cholestatic pruritus in...

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on November 8, 2024, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified...

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and...

Mirum Pharmaceuticals to Announce Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report third quarter 2024 financial results on November 12, 2024. Mirum will also host a conference call to discuss the...

Mirum Pharmaceuticals to Showcase LIVMARLI Data from its ALGS and PFIC Programs at the NASPGHAN Annual Meeting

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced its participation in the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) annual meeting...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
13.378.1935327011941.1348.8941.0956312243.74507064CS
45.0212.715298885539.4848.8938.1535471741.35120756CS
123.348.1146744412141.1648.8936.859137041840.59299764CS
2619.275.889328063225.348.8923.8356984736.13322124CS
5213.4743.409603609431.0348.8923.1457880732.21335134CS
15628.67181.11181301315.8348.8912.8243463327.86908473CS
26037.13503.7991858897.3748.896.512632552625.92519911CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SMCXDefiance Daily Target 2X Long SMCI ETF
$ 1.31
(33.67%)
1.4M
ERNAEterna Therapeutics Inc
$ 1.03
(23.35%)
912.56k
SMCISuper Micro Computer Inc
$ 22.10
(18.95%)
4.39M
AIRGAirgain Inc
$ 10.94
(17.01%)
1.04k
VINOGaucho Group Holdings Inc
$ 1.55
(13.14%)
3.16k
FLYEFly E Group Inc
$ 0.54
(-21.66%)
397.99k
QATiShares Trust iShares MSCI Qatar
$ 14.80
(-19.13%)
100
HUBCWHub Cyber Security Ltd
$ 0.0116
(-13.43%)
2.03k
KLTOKlotho Neurosciences Inc
$ 0.2898
(-12.45%)
4.04k
ELWSEarlyworks Co Ltd
$ 2.64
(-12.00%)
15.63k
ELABElevai Labs Inc
$ 0.0215
(-2.71%)
17.55M
IOVAIovance Biotherapeutics Inc
$ 8.22
(0.49%)
8.84M
HOODRobinhood Markets Inc
$ 32.68
(1.11%)
6.78M
CEROCERo Therapeutics Holdings Inc
$ 0.26
(-8.87%)
6.4M
SMCISuper Micro Computer Inc
$ 22.10
(18.95%)
4.39M

Your Recent History

Delayed Upgrade Clock